搜尋結果
2018
Wu, Y. W. ,
Hsu, K. C. ,
Lee, H. Y. ,
Huang, T. C. ,
Lin, T. E. ,
Chen, Y. L. ,
Sung, T. Y. ,
Liou, J. P. ,
Hwang-Verslues, W. W. ,
Pan, S. L. &
HuangFu, W. C. ,
3月 13 2018 ,
於: Frontiers in Pharmacology. 9 ,
MAR , 205.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tubulin Modulators
100%
In Vitro Techniques
26%
Tubulin
26%
Histone Deacetylase 6
19%
Neoplasms
19%
Sun, C. Y. ,
Wu, M. S. ,
Lee, C. C. ,
Chen, S. H. ,
Lo, K. C. &
Chen, Y. H. ,
12月 1 2018 ,
於: Scientific Reports. 8 ,
1 , 8085.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Organic Anion Transporters
100%
Nucleic Acid Regulatory Sequences
80%
Chronic Renal Insufficiency
63%
Single Nucleotide Polymorphism
58%
hepatoma-derived growth factor
41%
Jhan, M. K. ,
Huangfu, W. C. ,
Chen, Y. F. ,
Kao, J. C. ,
Tsai, T. T. ,
Ho, M. R. ,
Shen, T. J. ,
Tseng, P. C. ,
Wang, Y. T. &
Lin, C. F. ,
11月 2018 ,
於: Journal of Leukocyte Biology. 104 ,
5 ,
p. 961-968 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dengue Virus
100%
Encephalitis
51%
Dengue
27%
Virus Diseases
26%
Neurons
14%
Lu, M. L. ,
Chen, C. H. ,
Kuo, P. T. ,
Lin, C. H. &
Wu, T. H. ,
3月 2018 ,
於: Schizophrenia Research. 193 ,
p. 139-145 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
desmethylolanzapine
100%
Olanzapine
55%
Schizophrenia
37%
Metabolic Syndrome
18%
Drug Monitoring
7%
Chuang, S. Y. ,
Hsu, P. F. ,
Lin, F. J. ,
Huang, Y. W. ,
Wang, G. Z. ,
Chang, W. C. &
Tsai, H. J. ,
6月 2018 ,
於: British Journal of Clinical Pharmacology. 84 ,
6 ,
p. 1290-1300 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Atrial Fibrillation
100%
Anti-Inflammatory Agents
82%
Pharmaceutical Preparations
46%
Population
44%
National Health Programs
23%
Kuo, C. N. ,
Pan, J. J. ,
Huang, Y. W. ,
Tsai, H. J. &
Chang, W. C. ,
7月 1 2018 ,
於: Cancer Epidemiology Biomarkers and Prevention. 27 ,
7 ,
p. 737-745 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Case-Control Studies
100%
Colorectal Neoplasms
98%
Anti-Inflammatory Agents
91%
Pharmaceutical Preparations
51%
Population
48%
Shen, Y. L. ,
Liu, W. T. ,
Lee, K. Y. ,
Chuang, H. C. ,
Chen, H. W. &
Chuang, K. J. ,
2月 2018 ,
於: Environmental Pollution. 233 ,
p. 109-113 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Air Pollution
100%
sleep
94%
Air pollution
86%
Sleep Apnea Syndromes
82%
Sleep
80%
Kao, C-C. ,
Lin, Y-S. ,
Chu, H-C. ,
Fang, T-C. ,
Wu, M-S. &
Kang, Y-N. ,
9月 29 2018 ,
於: Journal of Clinical Medicine. 7 ,
10 研究成果: 雜誌貢獻 › 文章 › 同行評審
Network Meta-Analysis
100%
Hepacivirus
69%
Chronic Renal Insufficiency
68%
Antiviral Agents
63%
Kidney
39%
Liu, J. Y. ,
Hsiao, T. C. ,
Lee, K. Y. ,
Chuang, H. C. ,
Cheng, T. J. &
Chuang, K. J. ,
6月 15 2018 ,
於: Science of the Total Environment. 627 ,
p. 211-215 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Blood Pressure
100%
Air Pollution
69%
urban area
59%
Health
57%
Blood pressure
54%
Feng, P-H. ,
Chen, K-Y. ,
Huang, Y-C. ,
Luo, C-S. ,
Wu, S. M. ,
Chen, T-T. ,
Lee, C-N. ,
Yeh, C-T. ,
Chuang, H-C. ,
Han, C-L. ,
Lin, C-F. ,
Lee, W-H. ,
Kuo, C-H. &
Lee, K-Y. ,
7月 2018 ,
於: Journal of Thoracic Oncology. 13 ,
7 ,
p. 958-967 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Myeloid-Derived Suppressor Cells
100%
Bevacizumab
83%
Adenocarcinoma of Lung
80%
Protein-Tyrosine Kinases
68%
Progression-Free Survival
24%
Lee, A. W. ,
Lin, F. X. ,
Wei, P. L. ,
Jian-Wei, G. &
Chen, J. K. ,
1月 16 2018 ,
於: Journal of Nanobiotechnology. 16 ,
1 , 4.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Circulating Neoplastic Cells
100%
Assays
93%
Tumors
82%
Fibrous Crystal
80%
Cells
78%
Su, C. Y. ,
Chen, M. ,
Chen, L. C. ,
Ho, Y. S. ,
Ho, H. O. ,
Lin, S. Y. ,
Chuang, K. H. &
Sheu, M. T. ,
11月 1 2018 ,
於: Drug Delivery. 25 ,
1 ,
p. 1066-1079 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Bispecific Antibodies
100%
Lecithins
90%
human ERBB2 protein
87%
Docetaxel
79%
Nanocarrier
76%
Kao, C. C. ,
Liu, J. S. ,
Chang, Y. K. ,
Lin, M. H. ,
Lin, Y. C. ,
Chen, H. H. ,
Chang, W. C. ,
Hsu, C. C. &
Wu, M. S. ,
1月 1 2018 ,
於: PeerJ. 2018 ,
11 , e5864.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mammalian Target of Rapamycin Inhibitor
100%
kidney transplant
85%
Kidney Transplantation
54%
Antineoplastic Agent
51%
neoplasms
44%
Chiang, W. F. ,
Cheng, T. M. ,
Chang, C. C. ,
Pan, S. H. ,
Changou, C. A. ,
Chang, T. H. ,
Lee, K. H. ,
Wu, S. Y. ,
Chen, Y. F. ,
Chuang, K. H. ,
Shieh, D. B. ,
Chen, Y. L. ,
Tu, C. C. ,
Tsui, W. L. &
Wu, M. H. ,
1月 4 2018 ,
於: Oncogene. 37 ,
1 ,
p. 116-127 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Carcinoembryonic Antigen
100%
Cell Adhesion Molecules
98%
Glycosylation
90%
ErbB Receptors
84%
Squamous Cell Carcinoma
73%
Hsu, C. K. ,
Lin, H. H. ,
Harn, H. I. ,
Ogawa, R. ,
Wang, Y-K. ,
Ho, Y. T. ,
Chen, W. R. ,
Lee, Y. C. ,
Lee, J. Y. Y. ,
Shieh, S. J. ,
Cheng, C. M. ,
McGrath, J. A. &
Tang, M. J. ,
1月 2018 ,
於: Journal of Investigative Dermatology. 138 ,
1 ,
p. 208-218 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Trichostatin A
100%
Keloid
75%
Caveolin 1
73%
Fibroblasts
42%
Germane
40%
Liu, H. M. ,
Bai, C. H. ,
Liou, C. M. ,
Chiou, H. Y. &
Chen, C. ,
4月 3 2018 ,
於: Current Eye Research. 43 ,
4 ,
p. 460-465 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Meta-Analysis
100%
Systematic Reviews
98%
Corneal Edema
90%
Confidence Intervals
79%
Cornea
62%
Chi, N. F. ,
Ku, H. L. ,
Chen, D. Y. T. ,
Tseng, Y. C. ,
Chen, C. J. ,
Lin, Y. C. ,
Hsieh, Y. C. ,
Chan, L. ,
Chiou, H. Y. ,
Hsu, C. Y. &
Hu, C. J. ,
12月 1 2018 ,
於: Scientific Reports. 8 ,
1 , 16803.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Stroke
100%
Motor Cortex
59%
Multivariate Analysis
20%
Magnetic Resonance Imaging
19%
Odds Ratio
18%
Li, T. M. ,
Yu, Y. H. ,
Tsai, F. J. ,
Cheng, C. F. ,
Wu, Y. C. ,
Ho, T. J. ,
Liu, X. ,
Tsang, H. ,
Lin, T. H. ,
Liao, C. C. ,
Huang, S. M. ,
Li, J. P. ,
Lin, J. C. ,
Lin, C. C. ,
Liang, W. M. &
Lin, Y. J. ,
3月 1 2018 ,
於: Journal of Ethnopharmacology. 213 ,
p. 92-100 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Herbal Medicine
100%
Taiwan
88%
Safety
76%
Lung Neoplasms
70%
Molecular Cluster
58%
Putri, D. U. ,
Feng, P. H. ,
Hsu, Y. H. ,
Lee, K. Y. ,
Jiang, F. W. ,
Kuo, L. W. ,
Chen, Y. J. &
Han, C. L. ,
3月 2018 ,
於: Proteomics - Clinical Applications. 12 ,
2 , 1700040.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Pemetrexed
100%
Cisplatin
60%
Proteomics
51%
Non-Small Cell Lung Carcinoma
50%
Membranes
33%
Chi, N. F. ,
Wen, C. P. ,
Liu, C. H. ,
Li, J. Y. ,
Jeng, J. S. ,
Chen, C. H. ,
Lien, L. M. ,
Lin, C. H. ,
Sun, Y. ,
Chang, W. L. ,
Hu, C. J. &
Hsu, C. Y. ,
10月 2 2018 ,
於: Journal of the American Heart Association. 7 ,
19 ,
p. e009856 e009856.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Clopidogrel
100%
Secondary Prevention
84%
Aspirin
80%
Stroke
59%
Propensity Score
34%
Su, C-Y. ,
Ho, H-O. ,
Chen, Y-C. ,
Yu, Y-T. ,
Liu, D-Z. ,
Chao, F-C. &
Sheu, M-T. ,
5月 25 2018 ,
於: Scientific Reports. 8 ,
1 ,
p. 8092 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chang, P. Y. ,
Chien, L. N. ,
Bai, C. H. ,
Lin, Y. F. &
Chiou, H. Y. ,
3月 13 2018 ,
於: Therapeutics and Clinical Risk Management. 14 ,
p. 511-521 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
end stage renal disease
100%
Antidiabetic Agent
80%
Continuity of Patient Care
76%
hospitalization
73%
Medical problems
72%
Nepali, K. ,
Kumar, S. ,
Huang, H. L. ,
Kuo, F. C. ,
Lee, C. H. ,
Kuo, C. C. ,
Yeh, T. K. ,
Li, Y. H. ,
Chang, J. Y. ,
Liou, J. P. &
Lee, H. Y. ,
1月 1 2018 ,
於: Organic and Biomolecular Chemistry. 16 ,
25 ,
p. 4734 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dione
100%
HSP90 Heat-Shock Proteins
86%
Tubulin
70%
Antineoplastic Agents
62%
Antineoplastic Agent
58%
Siaw, M. Y. L. ,
Malone, D. C. ,
Ko, Y. &
Lee, J. Y. C. ,
12月 2018 ,
於: Journal of Clinical Pharmacy and Therapeutics. 43 ,
6 ,
p. 775-783 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Singapore
100%
Risk Management
94%
Cost-Benefit Analysis
74%
Randomized Controlled Trials
58%
Costs and Cost Analysis
46%
Chang, C. C. ,
Chen, T. L. ,
Lin, C. S. ,
Chung, C. L. ,
Yeh, C. C. ,
Hu, C. J. ,
Lane, H. L. ,
Liao, C. C. &
Shih, C. C. ,
5月 1 2018 ,
於: PLoS One. 13 ,
5 , e0196094.
研究成果: 雜誌貢獻 › 文章 › 同行評審
acupuncture
100%
cohort studies
90%
risk reduction
83%
stroke
73%
pneumonia
71%
Chen, L. C. ,
Tseng, H. J. ,
Liu, C. Y. ,
Huang, Y. Y. ,
Yen, C. C. ,
Weng, J. R. ,
Lu, Y. L. ,
Hou, W. C. ,
Lin, T. E. ,
Pan, I. H. ,
Huang, K. K. ,
Huang, W. J. &
Hsu, K. C. ,
7月 3 2018 ,
於: Frontiers in Pharmacology. 9 ,
JUL , 708.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Diarylheptanoids
100%
Histone Deacetylases
75%
Amyloid
61%
Pyrogallol
34%
Alzheimer Disease
33%
Su, C. Y. ,
Liu, J. J. ,
Ho, Y. S. ,
Huang, Y. Y. ,
Chang, V. H. S. ,
Liu, D. Z. ,
Chen, L. C. ,
Ho, H. O. &
Sheu, M. T. ,
2月 1 2018 ,
於: European Journal of Pharmaceutics and Biopharmaceutics. 123 ,
p. 9-19 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lecithins
100%
Docetaxel
87%
Drug Delivery Systems
76%
Therapeutics
12%
Neoplasms
10%
Kachingwe, B. H. ,
Uang, Y. S. ,
Huang, T. J. ,
Wang, L. H. &
Lin, S. J. ,
1月 2018 ,
於: Journal of Food and Drug Analysis. 26 ,
1 ,
p. 401-408 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
pharmacokinetics
100%
tandem mass spectrometry
96%
Hepatitis B virus
94%
drug development
87%
Pharmacokinetics
77%
Chi, N. F. ,
Kuan, Y. C. ,
Huang, Y. H. ,
Chan, L. ,
Hu, C. J. ,
Liu, H. Y. ,
Chiou, H. Y. &
Chien, L. N. ,
1月 1 2018 ,
於: Clinical Epidemiology. 10 ,
p. 1001-1011 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Epilepsy
100%
Stroke
81%
Point-of-Care Systems
14%
National Health Programs
13%
Calibration
13%
Chiu, H. H. ,
Liao, H. W. ,
Shao, Y. Y. ,
Lu, Y. S. ,
Lin, C. H. ,
Tsai, I. L. &
Kuo, C. H. ,
8月 17 2018 ,
於: Analytica Chimica Acta. 1019 ,
p. 93-102 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
antibody
100%
Calibration
97%
purification
88%
Blood Proteins
83%
drug
76%
Chen, Y. J. ,
Chen, M. ,
Hsieh, Y. C. ,
Su, Y. C. ,
Wang, C. H. ,
Cheng, C. M. ,
Kao, A. P. ,
Wang, K. H. ,
Cheng, J. J. &
Chuang, K. H. ,
12月 1 2018 ,
於: Scientific Reports. 8 ,
1 , 17868.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Gastrin-Secreting Cells
100%
Enzyme-Linked Immunosorbent Assay
53%
Antibodies
37%
Proteins
28%
Polystyrenes
20%
Chao, S. W. ,
Chen, L. C. ,
Yu, C. C. ,
Liu, C. Y. ,
Lin, T. E. ,
Guh, J. H. ,
Wang, C. Y. ,
Chen, C. Y. ,
Hsu, K. C. &
Huang, W. J. ,
1月 1 2018 ,
於: European Journal of Medicinal Chemistry. 143 ,
p. 792-805 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
indole
100%
Histone Deacetylases
89%
Histone
82%
Indole
71%
Carbon
37%
Tsai, Y. C. ,
Zeng, T. ,
Abou-Kheir, W. ,
Yeh, H. L. ,
Yin, J. J. ,
Lee, Y. C. ,
Chen, W. Y. &
Liu, Y. N. ,
2月 19 2018 ,
於: Molecular Cancer. 17 ,
1 ,
p. 42 42.
研究成果: 雜誌貢獻 › 文章 › 同行評審
ErbB Receptors
100%
Protein-Tyrosine Kinases
95%
Prostatic Neoplasms
83%
Genes
42%
Castration
9%
Kachingwe, B. H. ,
Wang, L-H. ,
Uang, Y-S. ,
Huang, T-J. &
Lin, S-J. ,
9月 1 2018 ,
於: Biomedical Chromatography. 32 ,
9 ,
p. e4266 e4266.
研究成果: 雜誌貢獻 › 文章 › 同行評審
isosteviol
100%
Anti Hepatitis
75%
Hepatitis B
48%
Dose
38%
Pharmacokinetics
37%
Chen, C. H. ,
Changou, C. A. ,
Hsieh, T. H. ,
Lee, Y. C. ,
Chu, C. Y. ,
Hsu, K. C. ,
Wang, H. C. ,
Lin, Y. C. ,
Lo, Y. N. ,
Liu, Y. R. ,
Liou, J. P. &
Yen, Y. ,
3月 1 2018 ,
於: Clinical Cancer Research. 24 ,
5 ,
p. 1176-1189 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
MPT0L145
100%
Urinary Bladder Neoplasms
39%
Autophagy
21%
Cell Death
13%
Smegmamorpha
6%
Chi, N. F. ,
Hu, H. H. ,
Wang, C. Y. ,
Chan, L. ,
Peng, C. K. ,
Novak, V. &
Hu, C. J. ,
11月 1 2018 ,
於: Stroke. 49 ,
11 ,
p. 2605-2611 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Homeostasis
100%
Stroke
93%
Infarction
28%
Arterial Pressure
27%
ROC Curve
14%
Lin, Y. C. ,
Chien, S. C. ,
Hsieh, Y. C. ,
Shih, C. M. ,
Lin, F. Y. ,
Tsao, N. W. ,
Chen, C. W. ,
Kao, Y. T. ,
Chiang, K. H. ,
Chen, W. T. ,
Chien, L. N. &
Huang, C. Y. ,
7月 31 2018 ,
於: Journal of the American College of Cardiology. 72 ,
5 ,
p. 477-485 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Rivaroxaban
100%
Atrial Fibrillation
67%
Safety
44%
Hemorrhage
21%
Myocardial Infarction
12%
Hu, P. J. ,
Wu, M. Y. ,
Lin, T. C. ,
Chen, T. T. ,
Wu, Y. C. ,
Su, S. L. ,
Lu, K. C. ,
Chen, J. S. ,
Sung, F. C. ,
Lee, C. T. ,
Yang, Y. ,
Hwang, S. J. ,
Wang, M. C. ,
Hsu, Y. H. ,
Chiou, H. Y. ,
Wong, C. S. &
Lin, Y. F. ,
12月 1 2018 ,
於: Scientific Reports. 8 ,
1 , 16276.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Hydroxymethylglutaryl-CoA Reductase Inhibitors
100%
Chronic Renal Insufficiency
94%
Kidney
55%
Disease Progression
44%
Odds Ratio
42%
Chen, Y. H. ,
Kuo, T. T. ,
Huang, E. Y. K. ,
Chou, Y. C. ,
Chiang, Y. H. ,
Hoffer, B. J. &
Miller, J. ,
2018 ,
於: Oncotarget. 9 ,
11 ,
p. 10016-10028 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nucleus Accumbens
100%
Nicotine
91%
Traumatic Brain Injury
90%
Dopamine
77%
Percussion
62%
Chen, Y-R. ,
Hsieh, F-I. ,
Chang, C-C. ,
Chi, N-F. ,
Wu, H-C. &
Chiou, H-Y. ,
5月 15 2018 ,
於: American Journal of Cardiology. 121 ,
10 ,
p. 1271-1277 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Rheumatoid Arthritis
100%
Anti-Inflammatory Agents
88%
Myocardial Infarction
87%
Stroke
82%
Pharmaceutical Preparations
49%
Tsai, F. J. ,
Li, T. M. ,
Cheng, C. F. ,
Wu, Y. C. ,
Lai, C. H. ,
Ho, T. J. ,
Liu, X. ,
Tsang, H. ,
Lin, T. H. ,
Liao, C. C. ,
Huang, S. M. ,
Li, J. P. ,
Lin, J. C. ,
Lin, C. C. ,
Liang, W. M. &
Lin, Y. J. ,
6月 12 2018 ,
於: Journal of Ethnopharmacology. 219 ,
p. 71-80 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Herbal Medicine
100%
Hyperlipidemias
90%
Taiwan
88%
Antiretroviral
85%
Cardiovascular Diseases
64%
Lin, Y. C. ,
Lin, Y. C. ,
Peng, C. C. ,
Chen, K. C. ,
Chen, H. H. ,
Fang, T. C. ,
Sung, S. Y. &
Wu, M. S. ,
3月 3 2018 ,
於: Nutrients. 10 ,
3 , 300.
研究成果: 雜誌貢獻 › 文章 › 同行評審
renal function
100%
Peritoneal Dialysis
90%
dialysis
85%
cholesterol
63%
Cholesterol
61%
Liu, C-W. ,
Lee, J-A. ,
Albert Sun, Y-T. ,
BenDao, M-K. &
Lin, C-R. ,
10月 15 2018 ,
於: Applied Surface Science. 455 ,
p. 581-590 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Photodetectors
100%
Diamond films
87%
Diamonds
77%
Diamond
73%
interlayers
70%
Wu, J. Y. ,
Chang, Y. T. ,
Lin, Y. C. ,
Lee, C. H. ,
Loh, E. W. ,
Wu, M. Y. ,
Chang, Y. S. &
Tam, K. W. ,
11月 1 2018 ,
於: Pharmacotherapy. 38 ,
11 ,
p. 1106-1119 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
lesinurad
100%
Hyperuricemia
64%
Gout
62%
Xanthine Oxidase
49%
Meta-Analysis
38%
Benign Paroxysmal Positional Vertigo
100%
Central Nervous System Diseases
76%
Migraine Disorders
15%
Therapeutics
11%
Age Distribution
8%
Kamiza, A. B. ,
Wang, W. C. ,
You, J. F. ,
Tang, R. ,
Wang, Y. T. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
Hsiung, C. A. &
Yeh, C. C. ,
10月 1 2018 ,
於: Anticancer Research. 38 ,
10 ,
p. 5983-5990 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Transforming Growth Factor-beta Type II Receptors
100%
Hereditary Nonpolyposis Colorectal Neoplasms
92%
ErbB Receptors
67%
Colorectal Neoplasms
55%
Genotype
36%
Wang, W. C. ,
Chou, C. K. ,
Chuang, M. C. ,
Li, Y. C. &
Lee, J. A. ,
2月 2018 ,
於: Biomedical Chromatography. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pyruvaldehyde
100%
Methylglyoxal
94%
Hepatitis
66%
Lactic Acid
63%
Liver
36%
Hsieh, C. L. ,
Koga, R. ,
Furusho, A. ,
Akita, T. ,
Mita, M. ,
Ide, T. ,
Lee, J. A. &
Hamase, K. ,
3月 2018 ,
於: Journal of Separation Science. 41 ,
6 ,
p. 1298-1306 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Plasma (human)
100%
High performance liquid chromatography
83%
3-Hydroxybutyrate
78%
Lactate
54%
Enantiomers
46%
Lin, Y. W. ,
Huang, C. Y. ,
Shih, C. M. ,
Tsai, Y. T. ,
Lin, C. S. ,
Lin, C. Y. ,
Li, C. Y. ,
Loh, S. H. ,
Lin, C. Y. ,
Lin, F. Y. &
Tsai, C. S. ,
1月 1 2018 ,
於: American Journal of Translational Research. 10 ,
10 ,
p. 3133-3149 17 p. , AJTR0081221.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chemokine CCL24
100%
Thrombomodulin
76%
Plasma Level
72%
THP-1 Cells
70%
Coronary Artery Bypass
55%